OpenVSafe by OpenVAERS
Search V-safe

GUW-11935-60983

2 vaccinations 5 coded responses 9 check-ins 3 free-text entries 1 call case
Sex
Male
Age at first dose
05-11
ZIP prefix
460 / IN
Registered
2022-10-16
Relationship
Child or adolescent in my care
Guardian
92V-32310-15178
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-08-01
    Dose 1 — Pfizer-BioNTech
  2. 2022-10-13
    Dose 2 — Pfizer-BioNTech
  3. 2022-10-16
    Registered in v-safe
  4. 2022-10-16
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  5. 2022-10-18
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · None
    Adult check-in
  6. 2022-10-20
    Survey response — day 7, dose 2, dependent
    MedDRA: Injection site discolouration — Feeling: Good
    Free text: Arm is discolored where bandaid covered injection site
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-11-03
    Survey response — day 21, dose 2, dependent
    MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair
    Free text: Cough (especially in the morning) & runny nose/congestion
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-11-12
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  9. 2022-11-17
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  10. 2022-11-24
    Survey response — day 42, dose 2, dependent
    MedDRA: Cough, Influenza, Pyrexia, Respiratory syncytial virus infection, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Currently have the flu and RSV- fever, cough, congestion
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-11-24
    Report sent to call center — day 42, dose 2, dependent
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  12. 2022-11-25
  13. 2023-01-12
    Survey response — 3 months, dose 2, dependent
    MedDRA: Eczema, Pruritus — Feeling: Fair
    MedDRA releases: 2024-11
  14. 2023-04-13
    Survey response — 6 months, dose 2, dependent
    MedDRA: Eczema — Feeling: Fair
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-08-01Pfizer-BioNTech No
22022-10-13Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 — day 7, dose 2, dependent

2022-10-20

Systemic reaction (other): Arm is discolored where bandaid covered injection site

Release 12 — day 21, dose 2, dependent

2022-11-03

Symptoms: Cough (especially in the morning) & runny nose/congestion

Release 12 — day 42, dose 2, dependent

2022-11-24

Symptoms: Currently have the flu and RSV- fever, cough, congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDEczema · · ✓
SDInfluenza · · ✓
SDPruritus · · ✓
SDPyrexia · · ✓
SDRespiratory syncytial virus infection · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SROInjection site discolouration · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release